Management of Infertility

Management of Infertility, a new report from AHRQ’s Effective Health Care Program, summarizes the benefits and harms of treatments for unexplained infertility and infertility related to causes such as polycystic ovarian syndrome, endometriosis, tubal factor infertility, and male factor infertility.

The evidence-based practice report findings support strategies for infertility treatment, such as use of the drug Leterozole versus clomiphene. Authors also explored the harms associated with egg and sperm donation, found no correlation between infertility treatment and maternal cancer, and highlighted areas of research needed for patients and clinicians to make the best possible decisions.

The American College of Obstetricians and Gynecologists will use the report to update its clinical practice guidelines on how to treat infertility.

Select to Management of Infertility

Page last reviewed May 2019
Page originally created April 2019
Internet Citation: Management of Infertility. Content last reviewed May 2019. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/news/management-infertility.html
Back To Top